Troikaa Pharmaceuticals Ltd, Ahmedabad based Pharmaceutical company is upgrading its Dehardun manufacturing facility. The upgradation will be for parenteral emulsion unit, where company will be adding advanced technical equipments in the unit. The company will be investing Rs 16 crore, which is expected to be commissioned by early May 2008.

The company's recent innovation is Dynapar AQ 1ml, which is manufactured by the company as patented aquatech process. Conventional diclofenac injections are formulated as 75 mg/3ml and are recommended for painkiller, as against Dynapar injection will delivers 75 mg diclofenac sodium in just 1ml. The current manufacturing capacity of diclofenac is two million units per month.

Speaking to Pharmabiz, Ketan Patel, director, said, "We are conducting expansion at our parenteral emulsion unit because our major product Dynapar AQ 1ml is successful in a short period and is well accepted in the market. In Mumbai itself more than 90 per cent hospitals are using it and we are expecting same results in other states also. During last fiscal Dynapar AQ 1ml sales has contributed Rs 25 crore and same will likely to touch Rs 40 crore in current year".

The company has wide range of products for both the domestic and international markets. It produces drugs for pain management, anaesthesia and oral cardiology. At present its 140 products are in the pipeline and 10-12 more products are in the pipeline for the existing therapeutic area. The company is holding two patents and two more have filled.

The company has two manufacturing facilities at Ahmedabad and Dehradun. Its both the facilities are certified by the World Health Organisation. Troikaa has the capability to manufacture high quality critical care injectables, tablets and topical preparations. It holds patented technology platforms for various novel drug delivery system - Intra oral, oral, parenteral, sustain release and topical.

During 2007-08 it has achieved Rs 140 crore and for the next fiscal it is targeting a turnover of Rs 300 crore.